1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow VBI-2901e: new trials by email Literature Review of VBI-2901e trials Research Report on VBI-2901e
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant VBI-2901e - COVID-19, Coronavirus Infections | Phase 1 | Withdrawn | VBI Vaccines Inc. | 2023-03-01 | 2023-04-04 |
COVID-19 (1) · Coronavirus Infections (1) · Severe Acute Respiratory Syndrome (1)
Canada (1)